Word

LEUKOCARE

Status

Registered

Status Code

700

Status Date

Tuesday, September 26, 2023

Serial Number

97000722

Registration Number

7172256

Registration Date

Tuesday, September 26, 2023

Mark Type

4000

Filing Date

Sunday, August 29, 2021

Published for Opposition

Tuesday, May 30, 2023

Trademark Owner History

Leukocare AG - Original Registrant

Classifications

9 Chromatography apparatus for laboratory use

5 Pharmaceutical products, in particular chemical preparations for medical purposes, namely, for treating cancer, autoimmune diseases, cardiovascular diseases, neurodegenerative diseases, infectious diseases, endocrine diseases, gastrointestinal diseases, nephrological diseases, respiratory diseases, and ophthalmological diseases; pharmaceutical preparations in the form of antibodies for the treatment of cancer, autoimmune diseases, cardiovascular diseases, neurodegenerative diseases, infectious diseases, endocrine diseases, gastrointestinal diseases, nephrological diseases, respiratory diseases, and ophthalmological diseases; pharmaceutical chemical preparations for pharmaceutical or medical purposes, namely, viruses for the treatment of cancer, autoimmune diseases, cardiovascular diseases, neurodegenerative diseases, infectious diseases, endocrine diseases, gastrointestinal diseases, nephrological diseases, respiratory diseases, and ophthalmological diseases

1 Proteins in purified raw form for scientific and medical research purposes; Proteins for industrial use by the pharmaceutical industry; Proteins for use in manufacture

10 Medical apparatus for use in treating of cancer, autoimmune diseases, cardiovascular diseases, neurodegenerative diseases, infectious diseases, endocrine diseases, gastrointestinal diseases, nephrological diseases, respiratory diseases, ophthalmological diseases; surgical implants comprising artificial material

42 Science and technology services being research and development in the pharmaceutical and biotechnology fields; pharmaceutical formulations, pharmaceutical ingredients, recombinant proteins, viruses and vaccines research and development; industrial analysis and research services in the field of pharmaceutical formulations, pharmaceutical ingredients, recombinant proteins, viruses and vaccines

LEUKO CARE

Trademark Events

Sep 26, 2023

Notice Of Registration Confirmation Emailed

Sep 26, 2023

Registered-Principal Register

Aug 24, 2023

1(B) Basis Deleted; Proceed To Registration

Jul 25, 2023

Notice Of Allowance Cancelled

Aug 24, 2023

Case Assigned To Intent To Use Paralegal

Jul 25, 2023

Teas Delete 1(B) Basis Received

Jul 25, 2023

Noa E-Mailed - Sou Required From Applicant

May 30, 2023

Official Gazette Publication Confirmation E-Mailed

May 30, 2023

Published For Opposition

May 10, 2023

Notification Of Notice Of Publication E-Mailed

Apr 25, 2023

Approved For Pub - Principal Register

Apr 7, 2023

Teas/Email Correspondence Entered

Apr 6, 2023

Correspondence Received In Law Office

Apr 6, 2023

Teas Request For Reconsideration Received

Mar 5, 2023

Notification Of Final Refusal Emailed

Mar 5, 2023

Final Refusal E-Mailed

Mar 5, 2023

Final Refusal Written

Jan 27, 2023

Teas/Email Correspondence Entered

Jan 27, 2023

Correspondence Received In Law Office

Jan 26, 2023

Assigned To Lie

Nov 28, 2022

Teas Response To Office Action Received

Jun 2, 2022

Notification Of Non-Final Action E-Mailed

Jun 2, 2022

Non-Final Action E-Mailed

Jun 2, 2022

Non-Final Action Written

Jun 2, 2022

Assigned To Examiner

Oct 13, 2021

New Application Office Supplied Data Entered

Sep 1, 2021

New Application Entered